Skip to content
Companies

Oncocyte

Molecular tests for cancer and transplant care

Raised to date

$21.7M

of $21.7M offered across 1 Form D filing

Investors
12
Last filed
Feb 24, 2025

About

Oncocyte Corporation is a leading molecular diagnostics company committed to enhancing patient outcomes through advanced diagnostic testing solutions tailored for oncology and transplant care. By focusing on delivering actionable insights, Oncocyte empowers healthcare professionals to make informed medical decisions critical to patient treatment pathways.

The company's unique commitment to merging cutting-edge technology with a patient-centric approach allows it to create personalized diagnostic solutions that directly address critical decision-making challenges in healthcare.

Funding

  • EquityFiled Feb 24, 2025Form D
    $21.7M/ $21.7M

Product

Molecular Diagnostic Tests

Diagnostic Testing

Oncocyte develops a comprehensive range of molecular diagnostic tests that enable healthcare providers to obtain vital patient information necessary for informed treatment decisions. These tests are strategically designed to be integrated seamlessly at key intervals throughout the treatment continuum.

  • Actionable diagnostic information
  • Focus on personalized insights
  • Application across oncology and transplant medicine

Built for

Healthcare providers, including physicians and clinical laboratories

People on file